Top: Health: Conditions and Diseases: Metabolic Disorders: Apo CII Deficiency


[ history ]

Disease Etiology

Apolipoprotein C-II is present as a peripheral apoprotein of chylomicrons, very low density lipoproteins (VLDLs), and intermediate density lipoproteins (IDLs). Apolipoprotein C-II activates lipoprotein lipase to hydrolyze triglycerides in the chylomicrons, VLDLs, and IDLs to release free fatty acids for cellular absorption. When the apoprotein is absent, lipoprotein lipase activity is compromised. This results in high triglyceride and chylomicron levels. LDL and HDL levels are abnormally low. The risk of atherosclerosis does not change significantly.



 All text is available under the terms of the GNU Free Documentation License. (See Copyright Policy for details.) 
© Open-Site Foundation, Inc.
Hosted by Android Technologies, Inc. the medical robotics news source.
Visit our sister sites dmoz.org | mozilla.org | chefmoz.org | musicmoz.org